Bottom line
RYSE vs FQTEX: the short answer
RYSE (Vest 10 Year Interest Rate Hedge ETF) and FQTEX (Franklin Templeton SMACS: Series E) are both etfs.
FQTEX is cheaper at 0% vs 0.94% — a difference of $94 a year per $10,000 invested.
Over one year, FQTEX returned +11.4% vs −3.8% for RYSE (reporting dates differ).
Updated Nov 19, 2026
RYSE vs FQTEX side by side
| RYSE | FQTEX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Grayscale | Franklin Templeton |
| Category | Other | Other |
| Expense ratio | 0.94% | 0% |
| Annual cost per $10k | $94 | $0 |
| 10-yr cost on $10k (prospectus) | $1,155 | $94 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −3.8% | +11.4% |
| 5-yr return (annualized) | — | +9.8% |
| 10-yr return (annualized) | — | — |
| Best quarter | +13.1% | +15.2% |
| Worst quarter | −10.7% | −23.2% |
| Net assets (fund) | — | $626.0M |
| Number of holdings | — | 114 |
| Portfolio turnover | % | 103% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RYSE | FQTEX | Difference |
|---|---|---|---|
| 2024 | +14.1% | +11.4% | +2.7% |
Source: Fund prospectus bar charts
Holdings overlap
RYSE and FQTEX share none of their top holdings.
RYSE top 10
FQTEX top 10
- Ares Management Corp. — 4.35%
- Boeing Co. (The) — 3.63%
- NextEra Energy, Inc. — 3.16%
- Shell plc — 3.04%
- Albemarle Corp. — 2.49%
- Medtronic plc — 2.36%
- UnitedHealth Group, Inc. — 2.13%
- Philip Morris International, Inc. — 1.91%
- TotalEnergies SE — 1.81%
- McDonald's Corp. — 1.78%
FAQ
What is the difference between RYSE and FQTEX?
RYSE (Vest 10 Year Interest Rate Hedge ETF) and FQTEX (Franklin Templeton SMACS: Series E) are both etfs. FQTEX is cheaper at 0% vs 0.94% — a difference of $94 a year per $10,000 invested.
Which is cheaper, RYSE or FQTEX?
FQTEX has the lower expense ratio (0%).
Should I own both RYSE and FQTEX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.